Beveridge RA - Search Results

1

Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation.

Horn TD, Beveridge RA, Egorin MJ, Abeloff MD, Hood AF. Horn TD, et al. Among authors: beveridge ra. Arch Dermatol. 1989 Apr;125(4):524-7. Arch Dermatol. 1989. PMID: 2539058

2

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE. Kennedy MJ, et al. Among authors: beveridge ra. J Natl Cancer Inst. 1991 Jul 3;83(13):920-6. doi: 10.1093/jnci/83.13.920. J Natl Cancer Inst. 1991. PMID: 1906111 Clinical Trial.

3

Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer.

Abeloff MD, Beveridge RA, Donehower RC, Fetting JH, Davidson NE, Gordon GG, Waterfield WC, Damron DJ. Abeloff MD, et al. Among authors: beveridge ra. J Natl Cancer Inst. 1990 Apr 4;82(7):570-4. doi: 10.1093/jnci/82.7.570. J Natl Cancer Inst. 1990. PMID: 2313733

4

Adjuvant chemotherapy of breast cancer--the Consensus Development Conference revisited.

Abeloff MD, Beveridge RA. Abeloff MD, et al. Among authors: beveridge ra. Oncology (Williston Park). 1988 Apr;2(4):21-6, 29-33. Oncology (Williston Park). 1988. PMID: 3079325 Review.

5

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.

Kennedy MJ, Vogelsang GB, Beveridge RA, Farmer ER, Altomonte V, Huelskamp AM, Davidson NE. Kennedy MJ, et al. Among authors: beveridge ra. J Clin Oncol. 1993 Mar;11(3):478-84. doi: 10.1200/JCO.1993.11.3.478. J Clin Oncol. 1993. PMID: 8445424 Clinical Trial.

6

Monitoring breast cancer with CA 549.

Chan DW, Beveridge RA, Bruzek DJ, Damron DJ, Bray KR, Gaur PK, Ettinger DS, Rock RC. Chan DW, et al. Among authors: beveridge ra. Clin Chem. 1988 Oct;34(10):2000-4. Clin Chem. 1988. PMID: 3168211

7

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.

Grem JL, Jordan E, Robson ME, Binder RA, Hamilton JM, Steinberg SM, Arbuck SG, Beveridge RA, Kales AN, Miller JA, et al. Grem JL, et al. Among authors: beveridge ra. J Clin Oncol. 1993 Sep;11(9):1737-45. doi: 10.1200/JCO.1993.11.9.1737. J Clin Oncol. 1993. PMID: 8355041 Clinical Trial.

8

A new biomarker in monitoring breast cancer: CA 549.

Beveridge RA, Chan DW, Bruzek D, Damron D, Bray KR, Gaur PK, Ettinger DS, Rock RC, Shurbaji MS, Kuhajda FP. Beveridge RA, et al. J Clin Oncol. 1988 Dec;6(12):1815-21. doi: 10.1200/JCO.1988.6.12.1815. J Clin Oncol. 1988. PMID: 3058875

9

CA-549: immunohistochemistry and serum levels in breast carcinoma and other neoplasms.

Shurbaji MS, Beveridge RA, Chan DW, Rock RC, Kuhajda FP. Shurbaji MS, et al. Among authors: beveridge ra. Ann Clin Lab Sci. 1989 Nov-Dec;19(6):408-14. Ann Clin Lab Sci. 1989. PMID: 2481424

10

Breast cancer marker Ca549. A multicenter study.

Chan DW, Beveridge RA, Bhargava A, Wilcox PM, Kennedy MJ, Schwartz MK. Chan DW, et al. Among authors: beveridge ra. Am J Clin Pathol. 1994 Apr;101(4):465-70. doi: 10.1093/ajcp/101.4.465. Am J Clin Pathol. 1994. PMID: 8160638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page